Roche announces FDA approval for VENTANA PDL1 SP142 Assay to support immunotherapy treatment decisions in lung cancer

TUCSON Ariz. Oct. 27 2016 PRNewswire Roche SIX RO ROG OTCQXRHHBY today announced approval of the VENTANA PDL1 SP142 Assay by the U.S. Food and Drug Administration FDA as a complementary diagno…
Read the full story: Bioportfolio Biomarker News